Takahito Sugase Selected Research

Takahito Sugase Research Topics

Disease

15	Neoplasms (Cancer) 12/2023 - 12/2016
14	Esophageal Neoplasms (Esophageal Cancer) 05/2024 - 01/2022
10	Esophageal Squamous Cell Carcinoma 05/2024 - 01/2017
9	Stomach Neoplasms (Stomach Cancer) 12/2023 - 10/2017
4	Neoplasm Metastasis (Metastasis) 02/2024 - 01/2019
2	Lymphatic Metastasis 01/2024 - 08/2017
2	Body Weight (Weight, Body) 09/2023 - 10/2022
2	Weight Loss (Weight Reduction) 05/2023 - 09/2022
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2023 - 01/2020
2	Uveal melanoma 01/2023 - 01/2019
2	Pancreatic Fistula (Pancreatic Fistulas) 10/2022 - 06/2022
2	Inflammation (Inflammations) 10/2021 - 10/2017
2	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 11/2018 - 12/2016
1	Osteoporosis 05/2023
1	Infections 01/2023
1	Surgical Wound Infection 01/2023
1	Thrombotic Microangiopathies 01/2023
1	Deglutition Disorders (Dysphagia) 09/2022
1	Pneumonia (Pneumonitis) 09/2022
1	Bile Duct Neoplasms (Bile Duct Cancer) 06/2022
1	Thrombosis (Thrombus) 02/2022
1	Peritonitis 09/2021
1	Lung Neoplasms (Lung Cancer) 01/2020
1	Margins of Excision 06/2018
1	Ovarian Neoplasms (Ovarian Cancer) 01/2018
1	Carcinoma (Carcinomatosis) 08/2017

Drug/Important Bio-Agent (IBA)

4	Therapeutic UsesIBA 07/2023 - 01/2023
3	Docetaxel (Taxotere)FDA Link 11/2023 - 06/2018
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 11/2023 - 01/2023
2	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 06/2018
2	Fluorouracil (Carac)FDA LinkGeneric 01/2022 - 06/2018
2	Lipoprotein Receptors (Lipoprotein Receptor)IBA 10/2021 - 08/2018
2	Proteins (Proteins, Gene)FDA Link 01/2019 - 01/2018
2	Biomarkers (Surrogate Marker)IBA 08/2018 - 10/2017
2	CytokinesIBA 01/2018 - 01/2017
1	NivolumabIBA 01/2024
1	fibrin fragment D (D-dimer)IBA 12/2023
1	pembrolizumabIBA 12/2023
1	OligodeoxyribonucleotidesIBA 06/2023
1	K3-SPGIBA 06/2023
1	Sizofiran (Schizophyllan)IBA 06/2023
1	AntigensIBA 01/2023
1	Environmental BiomarkersIBA 01/2023
1	CarbohydratesIBA 01/2023
1	3- (8- amino- 1- (2- phenylquinolin- 7- yl)imidazo(1,5- a)pyrazin- 3- yl)- 1- methylcyclobutanolIBA 01/2023
1	tegafur-gimeracil-oteracilIBA 01/2023
1	PotassiumIBA 01/2023
1	N-(2-naphthalene)sulfonyl-DL-tryptophan (A 91)IBA 01/2023
1	Insulin-Like PeptidesIBA 01/2023
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2023
1	YM-254890IBA 01/2023
1	AnticoagulantsIBA 01/2023
1	AlbuminsIBA 10/2022
1	Polyglactin 910IBA 10/2022
1	Polyglycolic Acid (Polyglycolide)IBA 10/2022
1	Hemoglobins (Hemoglobin)IBA 10/2022
1	Indicators and Reagents (Reagents)IBA 06/2022
1	Amylases FDA Link 10/2021
1	C-Reactive ProteinIBA 10/2021
1	Tyrosine Kinase InhibitorsIBA 01/2020
1	TAS-116IBA 01/2020
1	Immunoconjugates (Immunoconjugate)IBA 01/2020
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 01/2019
1	PLX51107IBA 01/2019
1	AZD4547IBA 01/2019
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 11/2018
1	Imatinib Mesylate (Gleevec)FDA Link 11/2018
1	Triglycerides (Triacylglycerol)IBA 08/2018
1	Lipoproteins (Lipoprotein)IBA 08/2018
1	LigandsIBA 01/2018
1	Janus KinasesIBA 01/2018
1	Leucine (L-Leucine)FDA Link 10/2017
1	GlypicansIBA 04/2017
1	Immunoglobulin G (IgG)IBA 04/2017
1	nilotinib FDA Link 12/2016

Therapy/Procedure

15	Esophagectomy 01/2024 - 06/2018
11	Therapeutics 02/2024 - 12/2016
11	Drug Therapy (Chemotherapy) 02/2024 - 10/2017
8	Gastrectomy 12/2023 - 08/2017
5	Neoadjuvant Therapy 05/2024 - 06/2022
3	Chemoradiotherapy 02/2024 - 01/2022
2	Length of Stay 09/2022 - 09/2021
1	Induction Chemotherapy 02/2024
1	Immunotherapy 02/2024
1	Adjuvant Chemotherapy 11/2023
1	Enhanced Recovery After Surgery 09/2023
1	Intraperitoneal Injections 01/2023
1	Pancreaticoduodenectomy 01/2023
1	Gastroenterostomy 11/2022
1	Sutures (Suture) 10/2022
1	Pancreatectomy 10/2022
1	Thrombectomy 02/2022
1	Splenectomy 01/2020
1	Molecular Targeted Therapy 08/2018
1	Withholding Treatment 12/2017
1	Aftercare (After-Treatment) 12/2017
1	Radiotherapy 12/2017
1	Lymph Node Excision (Lymph Node Dissection) 08/2017